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Abstract
Background: Flavonoids are recently being recognized for their important biological effects. Quercetin is a flavonoid that has
several pharmacological properties including anti-inflammatory, neuroprotective, and anticonvulsant effects.
Objectives: This study was designed to elucidate the role of quercetin in the gene expression of ionotropic glutamate receptor
subunits in kainic acid (KA)-induced seizure in mice.
Methods: This experimental study was conducted on 56 male BALB/c mice. Quercetin (50 and 100 mg/kg, intraperitoneally) was
administered 7 days before administration of KA. The hippocampi of the animals were removed and used for molecular analysis 2
hours and 7 days after KA administration.
Results: Pretreatment of mice with quercetin (100 mg/kg) significantly enhanced the gene expression of GluR1 subunit of AMPA
and NR2A and NR2B subunits of NMDA only 7 days after KA administration compared to the control and KA groups in the mice
hippocampus (P < 0.001, P < 0.001, and P < 0.05, respectively).
Conclusions: Increment of gene expression of subunits of AMPA and NMDA receptors by quercetin might explain its protective
effect on synaptic plasticity and memory.
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1. Background
Epilepsy is one of the most common neurological dis-
orders affecting approximately 1% of the general popula-
tion (1). About one-third of the patients have refractory
epilepsy, and temporal lobe epilepsy (TLE) is a form of par-
tial epilepsy in adults (2). Most of the available antiepilep-
tic drugs could control or reduce the occurrence of seizure.
Seizures induced by kainic acid (KA) exhibits neuropatho-
logical and electroencephalographic manifestations in pa-
tients with TLE (3). Fast excitatory glutamatergic neuro-
transmission in the central nervous system is mediated by
ligand-gated or ionotropic glutamate receptors, primar-
ily the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid (AMPA) receptor subtype. AMPA receptors have a crit-
ical role in excitatory glutamatergic neurotransmission.
There are four AMPA receptor subunits including GluA1 - 4
that are encoded by separate genes (4, 5).
The N-methyl-D-aspartate (NMDA) receptors are
among the other ionotropic glutamate receptors. They
are tetrameric ligand-gated ion channels comprising
GluN1, GluN2, and GluN3 subunits. Two different GluN2
subunits (GluN2A, GluN2B) have been identified in most
NMDA receptor–expressing cells (6). In the adult mouse
hippocampus, NR2A and NR2B are the predominant NR2
subunits of NMDA receptor (7).
Quercetin is a flavonoid that is found in vegetables
and fruits with several biological effects (8) including an-
tioxidative (9) anti-inflammatory (10), and neuroprotec-
tive (11) activities. We have earlier shown that quercetin
has anticonvulsant activity in acute and chronic models
of pentylenetetrazole (PTZ) (12, 13). Pretreatment with
quercetin (100 mg/kg) had a modulatory effect on β1 and
β3 subunits of GABAA receptor gene expression in a KA
model of epilepsy (14). It is important to know that at anti-
convulsant doses, quercetin causes molecular changes and
could modulate glutamate receptors. This led us to find
new target for treatment of epilepsy.
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2. Objectives
Thus, in the present study, we investigated the effect of
quercetin on the expression of genes encoding GluR1 sub-
unit of AMPA receptor as well as NR2A and NR2B subunits
of NMDA receptors in KA-induced seizure in hippocampus.
3. Methods
3.1. Animals
A total of 56 male BALB/c mice (20 - 25 g) were ob-
tained from the Razi Institute (Karaj, Iran) and housed in
groups of four per cage under standard laboratory condi-
tions. They were maintained at constant room tempera-
ture (21 ± 2°C) under a 12: 12 hour’s light-dark cycle with
free access to food and water. All animal experiments were
performed in accordance with the European communities
council directive of November 24, 1986 (86/609/EEC), so as
to minimize the number of animals used and their suffer-
ing.
3.2. Drugs
Quercetin and KA were purchased from Sigma (St
Louis, MO, USA). Other drugs used in this study included
xylazine (Loughrea, Co. Galway, Ireland) and ketamine (Ro-
texmedica, GmbH, Germany). Quercetin was dissolved in
0.8% v/v Tween 80, and KA was dissolved in saline.
3.3. KA Administration and Experimental Design
In this experimental study, mice were divided into four
groups. The control group (n = 8) was administered an in-
traperitoneal (i.p.) injection of saline + Tween 80 (10 ml/kg)
daily for 7 days, and on the last day, saline (10 mL/kg, i.p.)
was injected 30 minutes after administration of saline.
The kainic group (n = 16) was administered saline (10
ml/kg, i.p.) daily for 7 days, and on the last day, KA (10
mg/kg, i.p.) was injected 30 minutes after administration
of saline. In the two treatment groups (n = 16 in each
group), quercetin (50 and 100 mg/kg, i.p.) was adminis-
tered daily for 7 days, and on the last day, KA (10 mg/kg, i.p.)
was injected 30 minutes after administration of quercetin.
Then, half of the mice in each group after 2 hours
and another half after 7 days of KA administration were
anesthetized with i.p. injection of ketamine (60 mg/mL)/
xylazine (6 mg/kg) and were sacrificed. The hippocampi
of the animals were removed, cleaned with chilled saline
(0.9%), and used for molecular analysis.
3.4. Quantitative Real-Time Polymerase Chain Reaction
Total RNA from the hippocampus was extracted using
the total RNA extraction kit (Jena Bioscience, GmbH, Jena,
Germany). Then, the RNA was reverse transcribed using
the Revert Aid First Strand cDNA Synthesis Kit (Thermo Sci-
entific Fermentas, Waltham, MA, USA). The beta-actin gene
was used as an internal control for the quantification of
target genes expression. All primers for Gria2, Grin2A, and
Grin2B genes were designed using Gene Runner software
(version 3.05) as follows: Gria2 F: TGGCTTCCTCTATGGAT-
GCT, R: TTGCTATGGCAGGTGAAGAG; Grin2A F: GGGATGAC-
CAACGCTTAGTT R: CCTCAAGGATGACCGAAGAT; Grin2B F:
CCCACAGGGAAATCTGTCTT R: CCCACAGGGAAATCTGTCTT;
beta-actin F: TTACTGAGCTGCGTTTTACAC R: ACAAAGCCAT-
GCCAATGTTG. Quantitative real-time PCR was used to de-
tect the mRNA content of these genes in the hippocam-
pal tissues. The SYBR Green I real-time PCR assay was per-
formed in final reaction volumes of 20 µL with 10 µL of
SYBR Green I Master Mix (Bioneer, Korea), 10 pmol of for-
ward and reverse primers, and 20 ng of total RNA-derived
cDNAs. Thermal cycling was performed using the cali-
brated ABI-7500 (Applied Biosystems, Foster, CA, USA) Se-
quence Detection System under the following cycling con-
ditions: 10 minutes at 95°C for the first denaturation step,
followed by 40 cycles at 95°C for 20 seconds and 60°C for
45 seconds. Each complete amplification stage was fol-
lowed by dissociation stage at 95°C for 15 seconds, 60°C for 1
minute, and 95°C for 15 seconds. The values of cycle thresh-
old (Ct) obtained in quantification were used to calculate
fold changes in mRNA abundance according to the 2-∆∆Ct
method (15).
3.5. Statistical Analysis
Data were expressed as mean ± SEM and tested with
analysis of variance (ANOVA), followed by the multiple
comparison test of Tukey-Kramer. The analysis was com-
pleted using Prism software (5.04). P < 0.05 was consid-
ered to be statistically significant.
4. Results
All mice survived and were used for molecular analy-
ses. There were no significant changes in the hippocam-
pal GluR1 subunit gene expression levels between the KA
group after 2 hours and after 7 days of KA administration
and those in the control group animals (Table 1) (P> 0.05).
However, the level of GluR1 gene expression in the KA group
decreased after 7 days. It was observed that only quercetin
at a dose of 100 mg/kg could significantly increase GluR1
subunit gene expression compared to the control and KA
groups 7 days after KA administration (P < 0.001), whereas
2 Iran Red Crescent Med J. inpress(inpress):e42415.
Moghbelinejad S et al.
the expression level of the same gene at quercetin dose of
50 mg/kg was not significant in the hippocampus.
No significant difference was observed between the
level of NR2A subunit gene expression in the KA group and
that in the control group after 2 hours and 7 days of KA in-
jection in the hippocampus (Table 1) (P > 0.05). However,
quercetin (100 mg/kg) significantly increased the level of
NR2A subunit gene expression when data were compared
to those in the control and KA groups 7 days after KA admin-
istration in the hippocampus (P < 0.001).
There was also no significant difference between the
control and KA groups in the expression levels of NR2B sub-
unit gene after 2 hours and 7 days of KA injection (Table 1)
(P > 0.05). Quercetin at a dose of 100 mg/kg significantly
increased the level of NR2B subunit gene expression com-
pared to that in the control and KA groups on 7 days after
KA administration in the hippocampus (P < 0.05).
5. Discussion
This study demonstrated that the gene expression lev-
els of GluR1 subunit of AMPA receptor and NR2A and NR2B
subunits of NMDA receptors were not significantly differ-
ent in the KA group than the control group after 2 hours or
7 days of KA administration. However, pretreatment with
quercetin (100 mg/kg) increased the gene expression of
GluR1 and NR2A and NR2B subunits of glutamate receptors
7 days after administration of KA.
Status epilepticus for 1 hour could inhibit the expres-
sion of GluR1 - 4 subunit in the hippocampus of imma-
ture rats and adult rats (16). However, the role of reduc-
tion of AMPA receptors in epileptogenesis is still not clear.
Moreover, Solomonia et al. (2010) (17) reported that there
was no change in the expression of GluR1 subunit of AMPA
receptor after 28 - 30 hours of KA-induced status epilep-
ticus. However, they observed that on the 28th day of
study, the GluR1 levels reduced in the hippocampus of KA-
treated animals. Our results are consistent with their re-
sults, wherein the gene expression of GluR1 in the KA group
did not change significantly after 2 hours or 7 days of KA
administration. However, quercetin (100 mg/kg) increased
the expression of this gene. As we had shown earlier that
quercetin has anticonvulsant activities and inhibitory ef-
fects on lipid peroxidation (12, 13), we used KA to study any
induced subclinical change.
Lee et al. (2010) (18) showed that reversible phospho-
rylation of AMPA receptor GluR1 subunit is important in
the long-term potentiation (LTP) and long-term depression
(LTD). It seems that GluR1 involves in mediating the synap-
tic plasticity in the Schaffer collateral synapses onto CA1.
Therefore, it is possible that quercetin has an important
role in LTP and synaptic plasticity.
In patients with focal cortical dysplasia associated with
epilepsy, mRNA expression of GluR1 reduces in both dys-
plastic and heterotopic neurons. Furthermore, mRNA ex-
pression of NR2A and NR2B decreased and increased, re-
spectively, in dysplastic compared to heterotopic and pyra-
midal neurons (19). On the other hand, an immediate in-
crement in the expression of GluR1 and GluR2 was reported
after seizure (20) and repeated administration of AMPA re-
ceptor antagonists 48 hours after seizures could prevent
long-term increases in seizure susceptibility and seizure-
induced neuronal injury in the hippocampus at postna-
tal days 28 and 30 (21). Experimental limbic seizure made
changes in the protein expression of AMPA receptor sub-
units of GluR1 and GluR2 between 6 and 96 hours after sys-
temic injection of KA (22).
One important reason for the controversial results in
expression is the fact that the study populations (animal
or human), the model of seizure and applied toxin, and the
method for detection of changes are different. In addition,
some studies have focused on mRNA and others on protein
changes, which makes them difficult to compare.
Recurrent seizures induced by tetanus toxin or
flurothyl in infancy downregulated the expression of
NR2A and the associated scaffolding protein, PSD95, in
both hippocampus and neocortex. An interesting matter
in this study is that the postnatal day and numbers of
seizures were important in the intensity of NR2A down-
regulation (23). However, recurrent seizures in adult mice
could not alter NR2A expression. It was suggested that
the developing brain has a compensatory mechanism to
reduce the excitability of neurons against the hyperac-
tivity of recurrent seizure. On the other hand, the role of
NMDA receptors in learning and memory has been estab-
lished, and reduction of NMDA receptors could disturb
the maturation of synapses (23). In the knockout mice
without NMDA receptors, spatial learning and memory
were impaired (24).
Kinesin superfamily motor protein 17 (KIF17) is a can-
didate transporter of NMDA receptor NR2B subunit. It
was shown that this protein is necessary to preserve
NR2A/NR2B levels for memory process including acquisi-
tion, consolidation, and retrieval (7). In addition, it is
clear that NR2B is essential to maintain NR2A levels in neu-
rons (25) and parallel to this study, micro-RNA (miRNA) in-
terference knockdown and pharmacological approaches
showed that loss of NR2B function results in decreased lev-
els of NR2A via an increase in the proteasome-mediated
degradation of NR2A (7). The critical role of GluN2 subunits
in increasing learning and memory has been established
in the adult mouse brain. There is a relationship between
GluN2 subunit motifs, synaptic plasticity, and memory en-
hancement (26).
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Table 1. Effect of Quercetin on mRNA Ratio of Expression of GluR1, NR2A, and NR2B in KA-Induced Seizure in the Hippocampus of Micea , b
Treatment Glu P Value NR2A P Value NR2B P Value Statistical Test
Control 1.3± 0.21 > 0.05 0.28± 0.11 > 0.05 0.27± 0.09 > 0.05
Tukey-Kramer
KA-2 hours 1.29± 0.58 > 0.05 0.27± 0.09 > 0.05 0.24± 0.20 > 0.05
KA-7 days 1.098± 0.41 > 0.05 0.3± 0.16 > 0.05 0.28± 0.15 > 0.05
Q50-2 hours 0.96± 0.37 > 0.05 0.31± 0.21 > 0.05 0.24± 0.10 > 0.05
Q50-7 days 0.82± 0.22 > 0.05 0.27± 0.11 > 0.05 0.19± 0.03 > 0.05
Q100-2 hours 1.92± 0.33 > 0.05 0.72± 0.43 > 0.05 0.20± 0.12 > 0.05
Q100-7 days 4.2± 1.6 < 0.001 1.68± 0.56 < 0.001 0.72± 0.25 < 0.05
aData are expressed as mean± SEM.
bP < 0.05 and P < 0.001 for 100 mg/kg quercetin group compared to control and KA groups on day 7, Tukey-Kramer test, n = 8 mice.
Consistent with these reports, we observed that
quercetin at 100 mg/kg dosage could increase the gene
expression of NMDA receptor subunits, which might
explain that pretreatment with quercetin before seizure
could have an enhancing effect on synaptic plasticity
and memory. This hypothesis may be supported by the
evidence that quercetin improves memory in kindled rats
(12). Furthermore, quercetin has inhibitory effect against
PTZ in stimulated rat, because PTZ is a selective blocker
of the chloride channel coupled to the GABA receptor
complex. It was suggested that quercetin may have a
modulatory effect on GABAergic system (12).
This study showed the alterations of mRNA expression
in the subunits of AMPA and NMDA receptors following
quercetin administration using KA model of epilepsy in
mice. Further study is necessary to evaluate the effect of
quercetin on the expression of different excitatory and in-
hibitory neurotransmitter at transcriptomic and protein
levels probably involved in epilepsy.
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